Immunotherapy

Immunotherapy is the concept of using the immune system to treat disease, for example, developing a vaccine against cancer. Immunotherapy may also refer to the therapy of diseases caused by the immune system, allergies for example.
What is Immunotherapy?

Immunotherapy is a treatment that is designed to harness the ability of the body’s immune system to combat infection or disease.

Read More

Overview

Feature Articles

Latest Immunotherapy News and Research

Epigenetics drug used to treat blood cancers, rare sarcomas can halt bladder cancer growth

Epigenetics drug used to treat blood cancers, rare sarcomas can halt bladder cancer growth

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Targeted cognitive behavioral therapy can reduce food allergy-related anxiety for children and parents

Targeted cognitive behavioral therapy can reduce food allergy-related anxiety for children and parents

Collaboration aims to investigate ARTIDIS technology as novel treatment-optimization tool for solid tumors

Collaboration aims to investigate ARTIDIS technology as novel treatment-optimization tool for solid tumors

Research may lead to safer ways to care for patients impacted by blood clots

Research may lead to safer ways to care for patients impacted by blood clots

Effectiveness of anti-SARS-CoV-2 immunoadhesin against omicron and other emerging variants

Effectiveness of anti-SARS-CoV-2 immunoadhesin against omicron and other emerging variants

Treatment for neurological diseases often no longer effective enough in the later stages

Treatment for neurological diseases often no longer effective enough in the later stages

Shape-shifting mitochondria influence Th17 cells’ propensity for autoimmune activity

Shape-shifting mitochondria influence Th17 cells’ propensity for autoimmune activity

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

Giving immunotherapy before targeted therapy improves survival in patients with advanced melanoma

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

Scientists identify immune targets for chemotherapy-resistant breast cancers

Scientists identify immune targets for chemotherapy-resistant breast cancers

Cleveland Clinic’s ROBIN center may pave way for more effective radiation, immunotherapy treatments

Cleveland Clinic’s ROBIN center may pave way for more effective radiation, immunotherapy treatments

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Public-private collaboration receives grant for research on microbiota-boosted cancer therapy

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

Combination of three existing drugs extends survival in mouse models of lethal brain cancer

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy

Tumors generate unique, temporary cell-in-cell structures to evade immunotherapy

Research uncovers novel predictors of immune checkpoint inhibitor therapy for melanoma

Research uncovers novel predictors of immune checkpoint inhibitor therapy for melanoma

Study shows differences in treatment outcomes for Black vs. white women with hormone receptor-positive breast cancer

Study shows differences in treatment outcomes for Black vs. white women with hormone receptor-positive breast cancer

Higher levels of microbiota engraftment linked to greater chances of transplantation success

Higher levels of microbiota engraftment linked to greater chances of transplantation success

New immunotherapy approach may lead to an effective treatment for fibrosis

New immunotherapy approach may lead to an effective treatment for fibrosis

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes

Study highlights role of tumor-infiltrating B cells, plasma cells in cancer development and treatment outcomes